Chemomab Therapeutics Ltd. - Ordinary shares, no par value per share (CMMB) Institutional Ownership

CUSIP: 16385C203

13F Institutional Holders and Ownership History from Q3 2025 to Q4 2025

Type / Class
Equity / Ordinary shares, no par value per share
Symbol
CMMB on Nasdaq
Shares outstanding
491,982,609
Price per share
$1.55
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
367,379
Total reported value
$606,135
% of total 13F portfolios
0%
Share change
-25,306
Value change
-$247,038
Number of holders
14
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Investment Quick Answers

What is CUSIP 16385C203?
CUSIP 16385C203 identifies CMMB - Chemomab Therapeutics Ltd. - Ordinary shares, no par value per share in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Significant Owners of Chemomab Therapeutics Ltd. - Ordinary shares, no par value per share (CMMB) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
THIEL PETER 4.6% $40,509,848 22,631,200 Peter Thiel 31 Dec 2025

As of 31 Dec 2025, 14 institutional investors reported holding 367,379 shares of Chemomab Therapeutics Ltd. - Ordinary shares, no par value per share (CMMB). This represents 0.07% of the company’s total 491,982,609 outstanding shares.

Institutional Holders of Chemomab Therapeutics Ltd. - Ordinary shares, no par value per share (CMMB) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 367,379 $606,135 -$247,038 $1.65 14
2025 Q3 390,310 $1,026,521 +$1,011,399 $2.63 10